Exenatide
Smoking Cessation
The University of Texas Health Science Center, Houstonprotein_peptidePhase 1/2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Smoking Cessation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nicotine Brown University | Phase 4 | A |
Varenicline Tartrate University of California, San Diego | Phase 4 | A |
Varenicline Tartrate University of California, San Diego | Phase 4 | BBB |
Naltrexone Yale University | Phase 4 | BBB |
Varenicline Tartrate Corporal Michael J. Crescenz VA Medical Center | Phase 4 | BBB |
View all 34 →
Same molecule, other indications
Exenatide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →